Research and Markets has announced the addition of the "The New Arab Pharmacovigilance Guidelines" conference to their offering.
The new Arab pharmacovigilance guidelines were issued in May 2015 with their introduction on 1 July 2015. There are fundamental changes to pharmacovigilance practice described in these guidelines which follow the EU guidelines, issued and implemented in June 2012. This intensive two-day course will look at the various new topics and their practical application from the perspective of the introduction of the EU guidelines. The course will include experiences of inspections and audits following implementation and will identify what the main focus points will be.
09.30 An Introduction to the new PV Structure
09:45 Module I - Quality management systems
11:20 The Pharmacovigilance Systems Master File (PSMF - Module II)
13.45 Pharmacovigilance inspections (Module III)
15.20 Pharmacovigilance audits (Module IV)
17.00 Close of Day One
09.00 Risk Management Plans (RMPs - Module V)
10.15 Module VI - Adverse Reaction Reporting - Part 1
11:30 Module VI - Adverse Reaction Reporting - Part 2
13.45 PSURs/Module VII
15.35 Signals and their management (Module IX)
17.00 Final discussion and close of meeting
For more information about this conference visit http://www.researchandmarkets.com/research/gndpd2/the_new_arab
Related Topics: Drug Discovery
View source version on businesswire.com: http://www.businesswire.com/news/home/20160901006077/en/Business Wire
Last updated on: 01/09/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.